scholarly journals Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease: Design of the RESILIENT Randomized Controlled Trial (Preprint)

10.2196/32163 ◽  
2021 ◽  
Author(s):  
John A. Dodson ◽  
Antoinette Schoenthaler ◽  
Greg Sweeney ◽  
Ana Fonceva ◽  
Alicia Pierre ◽  
...  
Keyword(s):  
Older Adults ◽  
Randomized Controlled Trial ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Mobile Health ◽  
Controlled Trial ◽  
Ischemic Heart ◽  
Randomized Controlled ◽  
At Home

scholarly journals A randomized controlled trial of acupuncture in stable ischemic heart disease patients

2014 ◽  
Vol 176 (2) ◽  
pp. 367-374 ◽  
Author(s):  
Puja K. Mehta ◽  
Donna M. Polk ◽  
Xiao Zhang ◽  
Ning Li ◽  
Jeannette Painovich ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Controlled Trial ◽  
Ischemic Heart ◽  
Randomized Controlled ◽  
Stable Ischemic Heart Disease

scholarly journals Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease

2000 ◽  
Vol 15 (10) ◽  
pp. 685-693 ◽  
Author(s):  
Matthew W. Morgan ◽  
Raisa B. Deber ◽  
Hilary A. Llewellyn-Thomas ◽  
Peter Gladstone ◽  
R. J. Cusimano ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Decision Aid ◽  
Controlled Trial ◽  
Ischemic Heart ◽  
Interactive Videodisc ◽  
Randomized Controlled

Design of the RESILIENT Study: Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (Preprint)

2021 ◽  
Author(s):  
John A. Dodson ◽  
Antoinette Schoenthaler ◽  
Greg Sweeney ◽  
Ana Fonceva ◽  
Alicia Pierre ◽  
...  
Keyword(s):  
Older Adults ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Mobile Health ◽  
Goal Attainment ◽  
Functional Mobility ◽  
Ischemic Heart ◽  
Target Sample Size ◽  
Patterns Of Utilization ◽  
High Engagement

UNSTRUCTURED ABSTRACT Background: Participation in ambulatory cardiac rehabilitation (CR) remains low, especially among older adults. While mobile health CR (mHealth-CR) provides a novel opportunity to deliver care, age specific impairments may limit older adults’ uptake, and efficacy data are currently lacking. Methods/Design: The RESILIENT trial (NCT03978130) is a multicenter randomized clinical trial that is enrolling patients age ≥65 with ischemic heart disease in a 3:1 ratio to either intervention (mHealth-CR) or control (usual care), with a target sample size of 400 participants. mHealth-CR consists of a commercially available mHealth software platform coupled with weekly exercise therapist sessions to review progress and set new activity goals. The primary outcomes is change in functional mobility (6 minute walk distance) which is measured at baseline and 3 months. Secondary outcomes are health status, goal attainment, hospital readmission, and mortality. Among intervention participants, engagement with the mHealth-CR platform will be analyzed to understand characteristics that determine different patterns of utilization (e.g. persistent high engagement, declining engagement). Discussion: The RESILIENT trial will generate important evidence about the efficacy of mHealth-CR among older adults in multiple domains, as well as characteristics that determine sustained utilization of mHealth-CR. These findings will help in designing future precision medicine approaches to mHealth implementation in older adults. This knowledge is especially important in light of the COVID-19 pandemic which has shifted much of healthcare to the virtual setting.

Sign in / Sign up

Export Citation Format

Share Document